NEWARK, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarter Gross profit of $12.1

NEWARK, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ending December 31, 2025 before the market opens on Tuesday, March 10, 2026. Ultralife’s Management will also host an investor conference call and simultaneous

NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem,

NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife’s Management will also host an investor conference call and

NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025.

NEWARK, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has received an award valued at approximately $5.2 million from the U.S. Government’s Defense Logistics Agency (“DLA”) for its lithium manganese dioxide, non-rechargeable BA-5390 military batteries.

NEWARK, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2025 with the following results: Sales of $48.6 million increased 13.0% from $43.0 million for the second quarter of 2024; excluding Electrochem,

NEWARK, N.Y., July 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2025 before the market opens on Thursday, August 7, 2025. Ultralife’s Management will also host an investor conference call and simultaneous

NEWARK, N.Y., May 09, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2025 with the following highlights: Sales of $50.7 million compared to $41.9 million for the 2024 first quarter, including a 32.4% increase for

NEWARK, N.Y., April 29, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2025 before the market opens on Friday, May 9, 2025. Ultralife’s Management will also host an investor conference call and simultaneous webcast